Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingObservational

Discharge Medication Use Post-Operatively in GU Cancer Patients

NCT ID: NCT06795087Sponsor: Wake Forest University Health SciencesLast updated: 2026-01-22

Summary

The main purpose of this research study is to determine the amount of opioids that are taken after discharge following a cystectomy, nephrectomy (partial or total), or prostatectomy surgeries via a 30-day post- discharge opioid use and disposal survey. We will also evaluate the impact of an opioid disposal education pamphlet on proper disposal of unused opioids.

Detailed description

This prospective, non-therapeutic trial aims to evaluate the amount of prescribed opioid medications GU cancer patients are consuming post-discharge following surgical procedure of cystectomies, nephrectomies, and prostatectomies. Enrolled participants will complete a 30-day post-discharge survey evaluating the usage of prescribed opioids and opioid disposal habits, as well as a patient satisfaction survey. Furthermore, participants will be offered to complete an optional CAHPS® Surgical Care Survey to assess patients' experiences with surgical care during in hospital stay and outpatient office visits. Education on opioid medication disposal will be provided in the form of a pamphlet to participants that are enrolled beginning in year 2 (approximately month 13) from when the first participant is enrolled or after a minimum of 100 evaluable participants are enrolled in the pre-education cohort.

Arms & interventions

  • OtherOpioid Medication Disposal Education

    Education on opioid medication disposal will be provided in the form of a pamphlet created by Atrium Health based on FDA resources and will be given to all participants at discharge (cystectomy, nephrectomy, prostatectomy) beginning in the second year, approximately 13 months from when the first participant is enrolled or until a minimum of 100 evaluable participants are enrolled in the pre-education cohort, whichever occurs last.

Outcome measures

Primary

  • Discharge opioids consumed in 30 days after discharge

    For each participant who was prescribed an opioid medication after urology surgery, the number of opioid pills consumed in 30 days after discharge will be captured as a categorical variable from the "Opioid Use and Disposal Survey". Participant-reported options include None, About one-fourth of all pills, About half of all pills, About three-fourths of all pills, or All. Participants who report that they received an opioid prescription but did not fill it will be captured as taking None.

    Time frame: 30 days after discharge

Secondary

  • Number of participants filling opioid prescription

    Time frame: 30 days after discharge

  • Participant-reported reasons for not filling opioid prescription

    Time frame: 30 days after discharge

  • Participant-reported reasons for not taking all pills

    Time frame: 30 days after discharge

  • Participant-reported pain control after discharge

    Time frame: 30 days after discharge

  • Number of participants receiving a refill after discharge

    Time frame: 30 days after discharge

  • Participant-reported disposal method for left-over opioids

    Time frame: 30 days after discharge

  • Patient Satisfaction Survey Item 1 - "I would recommend this institution to a friend or family for treatment."

    Time frame: 30 days after discharge

  • Patient Satisfaction Survey Item 2 - "The staff provided adequate information and education prior to discharge regarding my recovery at home (ex. wound care and pain management)."

    Time frame: 30 days after discharge

  • Patient Satisfaction Survey Item 3 - "Prior to my discharge, I or my caregiver clearly understood the timing and purpose for taking each of my medications."

    Time frame: 30 days after discharge

  • Patient Satisfaction Survey Item 4 - "During the hospital stay, nurses and doctors treated me with courtesy and respect."

    Time frame: 30 days after discharge

  • Patient Satisfaction Survey Item 5 - "Following prostatectomy, I preferred to be discharged the same day."

    Time frame: 30 days after discharge

  • CAHPS Surgical Care Survey - Number of patients with top-box ratings of preparation for surgery

    Time frame: 30 days after discharge

  • CAHPS Surgical Care Survey - Number of patients with top-box ratings of preoperative communication

    Time frame: 30 days after discharge

  • CAHPS Surgical Care Survey - Number of patients with top-box ratings of day of surgery attentiveness

    Time frame: 30 days after discharge

  • CAHPS Surgical Care Survey - Patients' rating of surgeon

    Time frame: 30 days after discharge

  • CAHPS Surgical Care Survey - Patients' rating of anesthesiologist

    Time frame: 30 days after discharge

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria: 1. Written informed consent and HIPAA authorization for release of personal health information. 2. Age ≥ 18 years at the time of enrollment 3. Scheduled to undergo surgical cystectomy, partial or total nephrectomy or prostatectomy for a cancer diagnosis. 4. Ability to read and understand the English and/or Spanish language. 5. As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study. Exclusion Criteria: * None

Study locations (1)

Levine Cancer Institute

Charlotte, North Carolina, 28204

Recruiting
Margarita Dzhanumova · Contact
704-355-2000Margarita.Dzhanumova@advocatehealth.org
Stephen Riggs, MD · Principal Investigator